Skip to main content
Clinical Trials/ACTRN12608000215325
ACTRN12608000215325Recruiting未知

A study to measure the peak flow of infants aged 0-2 years with either healthy lungs or with bronchiolitis to determine peak flow values in both these groups.

Fisher and Paykel Healthcare0 sites60 target enrollmentStarted: April 21, 2008Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
Years to 2 Years (—)
Sex
All

Inclusion Criteria

  • 1. Infants aged 0-2 years
  • 2. Infants about to undergo surgery not related to their respiratory system (healthy lung group)
  • 3. Infants diagnosed with bronchiolitis in repsiratory failure (lung sick group)

Exclusion Criteria

  • 1. Infants aged > 2 years
  • 2. Infants not breathing spontaneously
  • 3. Infants whose condition limits their ability to participate
  • 4. Infants where informed consent cannot be obtained from a parent or legal guardian

Investigators

Sponsor
Fisher and Paykel Healthcare

Similar Trials